LENZ Therapeutics (LENZ) Change in Acquisitions & Divestments (2022 - 2025)
LENZ Therapeutics (LENZ) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $43.3 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 24.18% to $43.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $206.0 million through Dec 2025, up 134.31% year-over-year, with the annual reading at $206.0 million for FY2025, 134.31% up from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $43.3 million at LENZ Therapeutics, down from $52.4 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $90.0 million in Q3 2022, with the low at $13.0 million in Q2 2024.
- Average Change in Acquisitions & Divestments over 3 years is $46.4 million, with a median of $47.7 million recorded in 2025.
- Peak annual rise in Change in Acquisitions & Divestments hit 347.08% in 2025, while the deepest fall reached 24.18% in 2025.
- Over 3 years, Change in Acquisitions & Divestments stood at $80.2 million in 2022, then plummeted by 56.51% to $34.9 million in 2024, then rose by 24.18% to $43.3 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $43.3 million, $52.4 million, and $58.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.